Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: Part 2. Synthesis of rigid pyrazolones

Daniele Castagnolo, Fabrizio Manetti, Marco Radi, Beatrice Bechi, Mafalda Pagano, Alessandro de Logu, Rita Meleddu, Manuela Saddi, Maurizio Botta

Research output: Contribution to journalArticlepeer-review

131 Citations (Scopus)
5 Downloads (Pure)

Abstract

Two series of novel rigid pyrazolone derivatives were synthesized and evaluated as inhibitors of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis. Two of these compounds showed a high activity against MTB (MIC = 4 μg/mL). The newly synthesized pyrazolones were also computationally investigated to analyze if their properties fit the pharmacophoric model for antitubercular compounds previously built by us. The results are in agreement with those reported by us previously for a class of pyrazole analogues and confirm the fundamental role of the p-chlorophenyl moiety at C4 in the antimycobacterial activity.
Original languageEnglish
Pages (from-to)5716-5721
JournalBioorganic & Medicinal Chemistry
Volume17
Issue number15
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: Part 2. Synthesis of rigid pyrazolones'. Together they form a unique fingerprint.

Cite this